Ability of dopamine antagonists to inhibit the locomotor effects of cocaine in sensitized and non-sensitized C57BL/6 mice depends on the challenge dose
1-adrenergic receptors in acute and sensitized locomotor effects of D-amphetamine, cocaine, and GBR 12783: Influence of preexposure conditions and pharmacological characteristics
1-adrenergic receptors in acute and sensitized locomotor effects of D-amphetamine, cocaine, and GBR 12783: influence of preexposure conditions and pharmacological characteristics. Synapse 43:51-61
2C receptors in nucleus accumbens regulate expression of the hyperlocomotive and discriminative stimulus effects of cocaine
2C receptors in nucleus accumbens regulate expression of the hyperlocomotive and discriminative stimulus effects of cocaine. Pharmacol Biochem Behav 71:745-756
Role of extracellular dopamine in the initiation and long-term expression of behavioral sensitization to cocaine
Heidbreder CA, Thompson AC, Shippenberg TS (1996) Role of extracellular dopamine in the initiation and long-term expression of behavioral sensitization to cocaine. J Pharmacol Exp Ther 278:490-502
Dopamine transmission in the initiation and expression of drug-induced and stress-induced sensitization of motor activity
Kalivas PW, Stewart J (1991) Dopamine transmission in the initiation and expression of drug-induced and stress-induced sensitization of motor activity. Brain Res Rev 16:223-244
Chronic cocaine administration: Sensitization and kindling effects
Fisher S, Raskin A, Uhlenhuth EH (eds). Oxford University Press, New York
Post RM, Weiss SR, Pert A, Uhde TW (1987) Chronic cocaine administration: sensitization and kindling effects. In: Fisher S, Raskin A, Uhlenhuth EH (eds) Cocaine: clinical and biobehavioral aspects. Oxford University Press, New York, pp 109-173
Repeated administration of cocaethylene induces context-dependent sensitization to its locomotor effects
Prinssen EP, Kleven MS, Koek W (1996a) Repeated administration of cocaethylene induces context-dependent sensitization to its locomotor effects. Psychopharmacology 124:300-305
Effects of repeated administration of N-[1-(2-benzo(b)thiophenyl) cyclohexyl]piperidine and cocaine on locomotor activity in C57BL/6 mice
Prinssen EP, Kleven MS, Vignon J, Kamenka JM, Koek W (1996b) Effects of repeated administration of N-[1-(2-benzo(b)thiophenyl)cyclohexyl]piperidine and cocaine on locomotor activity in C57BL/6 mice. J Pharmacol Exp Ther 276:904-911
Does crossing over repeated treatment with the dopamine reuptake inhibitors cocaine and BTCP modify their effects on cocaine induced locomotion?
Prinssen EP, Koek W, Vignon J, Kamenka JM, Kleven MS (1999) Does crossing over repeated treatment with the dopamine reuptake inhibitors cocaine and BTCP modify their effects on cocaine induced locomotion? Psychopharmacology 143:8-14
D-2 but not D-1 dopamine agonists produce augmented behavioral response in rats after subchronic treatment with methamphetamine or cocaine
Ujike H, Akiyama K, Otsuki S (1990) D-2 but not D-1 dopamine agonists produce augmented behavioral response in rats after subchronic treatment with methamphetamine or cocaine. Psychopharmacology 102:459-464
Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: A critical review of preclinical studies
Vanderschuren LJ, Kalivas PW (2000) Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies. Psychopharmacology 151:99-120
Context-dependent cocaine sensitization: Differential effect of haloperidol on development versus expression
Weiss S, Post RM, Pert A, Woodward R, Murman D (1989) Context-dependent cocaine sensitization: differential effect of haloperidol on development versus expression. Pharmacol Biochem Behav 34:655-661
Dopamine receptor antagonists fail to prevent induction of cocaine sensitization
White FJ, Joshi A, Koeltzow TE, Hu XT (1998) Dopamine receptor antagonists fail to prevent induction of cocaine sensitization. Neuropsychopharmacology 18:26-40